The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...

By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab), by the European Commission based on positive Phase 3 study ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has built a dynamic career in biopharma. Now the Global market development manager ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition. The phase 3 ICONIC-LEAD study showed that icotrokinra, ...

Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults. Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its ...

The financing round will fund the improvement of the company’s technology platform for the discovery and development of innovative radionuclide drug conjugates. C Ray Therapeutics has announced the ...

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of resilience and curiosity. Now leading the Biopharma product management team at ...

The global CDMO has entered into several high-value manufacturing deals this year. The global contract development and manufacturing organization (CDMO), Samsung Biologics, announced this week that it ...